The Bourque distances for mutation trees of cancers
Katharina Jahn1,2, Niko Beerenwinkel1,2, Louxin Zhang3
1Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
Algorithms for Molecular Biology : AMB
|June 11, 2021
Summary
We introduce Bourque distances, a new set of metrics to compare tumor mutation trees. This method overcomes limitations of existing tree comparison methods, enabling better analysis of cancer mutational history.
Area of Science:
- Computational Biology
- Bioinformatics
- Cancer Genomics
Background:
- Mutation trees, also known as clonal trees, model tumor mutational history.
- Traditional tree metrics like Robinson-Foulds distance are inadequate for comparing mutation trees due to differing mutation labels.
- This limitation hinders comparative analyses across different inference methods or patient datasets.
Purpose of the Study:
- To develop novel distance metrics for comparing mutation trees.
- To address the limitations of existing metrics in handling varied mutation labels.
- To facilitate more robust comparisons of tumor evolutionary histories.
Main Methods:
- Generalizing the Robinson-Foulds distance to create a new set of metrics, termed Bourque distances.
- Developing an efficient algorithm for computing the basic Bourque distance.
- Establishing a theoretical link between the Bourque distance and the nearest neighbor interchange distance.
Main Results:
- Introduced Bourque distances, a generalized set of metrics for mutation tree comparison.
- Demonstrated that the basic Bourque distance can be computed in linear time.
- Established a connection between Robinson-Foulds distance and nearest neighbor interchange distance.
Conclusions:
- Bourque distances offer a more effective approach for comparing mutation trees in computational oncology.
- The linear-time computation of the basic Bourque distance enhances its practical applicability.
- These new metrics advance the analysis of tumor evolution and comparative genomics.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
13.3K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.3K
Cancer-Critical Genes II: Tumor Suppressor Genes
8.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.4K
Cancer
51.3K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.3K
Cancer Survival Analysis
491
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
491
Tumor Progression
6.7K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.7K
Mutations
87.5K
Overview
87.5K


